The United States represents one of the most advanced and rapidly evolving hubs for cell-based bioprocessing activities, driven by strong biopharmaceutical infrastructure, high R&D investment, and widespread adoption of innovative therapeutic approaches. The country’s focus on regenerative medicine, immunotherapy, and precision medicine has significantly increased the demand for...